logo

For the Inventor, By the Inventor

Ahmedabad, India

Intas Pharmaceuticals Limited


USPTO Granted Patents = 19

% Expired Patents = 15.8



Forward Citations = 12

Loading Chart...
Loading Chart...

52 inventors (with patents filed for the assignee):

goldMedal Ashish Sehgal (6 out of 7 patents)

silverMedal Venkataramana Naidu (4 out of 4 patents)

bronzeMedal Rikin Patel (4 out of 4 patents)

4.  Piyush Kansagra (4 out of 4 patents)

5.  Himanshu Gadgil (3 out of 3 patents)

6.  Chandresh Chhatbar (3 out of 3 patents)

7.  Vijaykant Pandey (3 out of 3 patents)

8.  Balvir Singh (3 out of 5 patents)

9.  Mayank Saxena (3 out of 3 patents)

10.  Mettilda Lourdusamy (2 out of 2 patents)

11.  Ioan Iosif Radu (2 out of 2 patents)

12.  Satyavan Dhavale (2 out of 2 patents)

13.  Kavan Pandya (2 out of 2 patents)

14.  Manishkumar Jayantibhai Chauhan (2 out of 2 patents)

15.  Manish Mavjibhai Patel (2 out of 2 patents)


19 patents:

1. 12734167 - Naltrexone formulation (2026-09-15),
2. 12691142 - Essentially sodium-free effervescent solid pharmaceutical compositions (2026-07-28),
3. 12584143 - NOVEL COMBINATION OF TIS SEQUENCE AND SIGNAL PEPTIDE SEQUENCE FOR EXPRESSING A RECOMBINANT PROTEIN (2026-03-24),
4. 12433905 - Stable oral composition of cyclophosphamide (2025-10-07),
5. 12280053 - Stable, ready to use aqueous pharmaceutical composition of pemetrexed (2025-04-21),
6. 12269830 - Process for preparation of tofacitinib and pharmaceutically acceptable salt thereof (2025-04-08),
7. 11918590 - Stable extended release pharmaceutical composition of clozapine (2024-03-05),
8. 11833253 - Extended release pharmaceutical composition of Clozapine (2023-12-05),
9. 11648207 - Extended release pharmaceutical composition of Clozapine (2023-05-16),
10. 11504336 - Extended release pharmaceutical composition of clozapine (2022-11-22),
11. 11433058 - Non-pulsatile prolonged-release betahistine oral solid compositions (2022-09-06),
12. 10918698 - Lyophilized pharmaceutical composition of Fc-peptide fusion protein (2021-02-16),
13. 10688187 - Liquid pharmaceutical composition of adalimumab (2020-06-23),
14. 10052361 - Liquid pharmaceutical composition of conjugated erythropoietin (2018-08-21),
15. 10016447 - Pharmaceutical composition having improved content uniformity (2018-07-10),
Company Overview
Intas Pharmaceuticals Limited is a prominent player in the global pharmaceutical industry, specializing in the development and manufacturing of a diverse range of generic and specialty medications. The company focuses on therapeutic areas such as oncology, cardiology, and neurology, leveraging advanced research and technology to enhance healthcare outcomes. Headquartered in Ahmedabad, India, Intas is committed to innovation and quality, ensuring access to affordable medicines across various markets worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

19 Patents

#4 in Ahmedabad

#102 in India

#32,663 in the World

Ahmedabad, IN
Ahmedabad, India

Intas Pharmaceuticals Limited

Forward Citations = 12

52 inventors:

goldMedal Ashish Sehgal (6 out of 7 patents)

silverMedal Venkataramana Naidu (4 out of 4 patents)

bronzeMedal Rikin Patel (4 out of 4 patents)

4.  Piyush Kansagra (4 out of 4 patents)

5.  Himanshu Gadgil (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Intas Pharmaceuticals Limited. Retrieved from https://idiyas.com/company/intas-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…